What stocks does SBI HEALTHCARE OPPORTUNITIES FUND hold?

SBI HEALTHCARE OPPORTUNITIES FUND holds a portfolio of Indian equity stocks disclosed monthly by SBI Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is managed by SBI Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is SBI HEALTHCARE OPPORTUNITIES FUND portfolio data updated?

Portfolio holdings for SBI HEALTHCARE OPPORTUNITIES FUND are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of Jul 2026 Comparing Jun 2026 → Jul 2026

Share: WhatsApp X

⌕

Stocks Held

Jul 2026

Equity Holdings

₹5,307.69 Cr

Equity only, excl. debt & cash

AAUM

₹4,318.95 Cr

Apr-Jun 2026 · Direct + Regular

Top 5 Weight

35.4%

Moderate

Top 10 Weight

56.3%

Moderate

Changes

3 new · 1 exits

Top Sector

Pharmaceuticals & Biotechnology

66.8% of portfolio

Launch Date

01 Jan 1993

10+ year track record

AAUM (Average Assets Under Management) of ₹4,318.95 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND made 3 new additions and exited 1 stock this month. The biggest new buy was Jupiter Life Line Hospitals Limited (Healthcare Services) at 2.88% weight. Jupiter Life Line Hospitals Ltd was the biggest exit (Healthcare Services), which was held at 2.56%. Among existing holdings, Cipla Limited saw the biggest increase — now at 5.07% of the portfolio. Acutaas Chemicals Ltd was trimmed the most, now at 5.17%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 66.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

+3.56%

+11.29%

+18.53%

+18.62%

Latest NAV

₹595.32

24 Aug 2026

52W High

₹608.00

-2% from High

52W Low

₹442.50

+35% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+43.8%

2023

+39.7%

2022

-5.0%

2021

+21.5%

2020

+67.7%

2019

+0.5%

2018

-8.8%

2017

+3.3%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.8%

+ve in 66% windows

86.5% / -18.1%

3Y Rolling Avg

17.9% p.a.

+ve in 85% windows

32.2% / -9.6%

5Y Rolling Avg

18.8% p.a.

+ve in 100% windows

34.0% / 6.9%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-13.5%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-22.7%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.0%

Rec: May 2023 (1yr 4mo)

2018 IL&FS

-14.4%

Rec: Apr 2020 (2yr 1mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

1.38

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.00

Penalises downside volatility only.

Std Deviation (3Y)

12.8%

Lower = more consistent returns.

NAV Chart ₹595.32 24 Aug 2026

Simple Moving Avg: Click to draw · click again to remove

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Chart shows indexed performance (base = 100). Actual NAV: ₹595.32

Sector Shift Industry allocation month-over-month

May 2026 → Jun 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.9%	64.2%	▼ -0.7%
Healthcare Services	25.9%	26.1%	▲ +0.2%
Chemicals & Petrochemicals	2.7%	2.7%	● +0.1%
Healthcare Equipment & Supplies	1.9%	2.2%	▲ +0.3%

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.2%	66.8%	▲ +2.7%
Healthcare Services	26.1%	27.2%	▲ +1.1%
Chemicals & Petrochemicals	2.7%	2.3%	▼ -0.4%
Healthcare Equipment & Supplies	2.2%	2.0%	▼ -0.1%

🟢

Biggest New Buy

Jupiter Life Line Hospitals Limited

2.88% weight · Healthcare Services

🔴

Biggest Exit

Jupiter Life Line Hospitals Ltd

2.56% was held · Healthcare Services

↑

Biggest Add

Cipla Limited

+1.55% · now 5.07%

↓

Biggest Trim

Acutaas Chemicals Ltd

-1.18% · now 5.17%

🤝 Other funds also bought this month

Jupiter Life Line Hospitals Limited 32 funds

Syngene International Limited 6 funds

Healthcare Global Enterprises Limited 4 funds

👋 Other funds also exited

Jupiter Life Line Hospitals Ltd 32 funds

What Changed in the Portfolio This Month?

Comparing Jun 2026 → Jul 2026

Jun 2026 → Jul 2026

🟢 3 New Entries 🔴 1 Exit ↑ 9 Increased ↓ 20 Decreased

#	Stock	Sector	Weight (Jul 2026)
1	Jupiter Life Line Hospitals Limited ₹155.44 Cr	Healthcare Services	2.88%
2	Syngene International Limited ₹51.58 Cr	Healthcare Services	0.96%
3	Healthcare Global Enterprises Limited ₹39.53 Cr	Healthcare Services	0.73%

#	Stock	Sector	Last Weight (Jun 2026)
1	Jupiter Life Line Hospitals Ltd ₹127.88 Cr	Healthcare Services	2.56%

#	Stock	Sector	Jun 2026	Jul 2026	Change
1	Cipla Limited ₹274.02 Cr	Pharmaceuticals & Biotechnology	3.52%	5.07%	+1.55%
2	Sun Pharmaceutical Industries Limited ₹686.72 Cr	Pharmaceuticals & Biotechnology	11.18%	12.72%	+1.54%
3	Divi's Laboratories Limited ₹402.80 Cr	Pharmaceuticals & Biotechnology	5.92%	7.46%	+1.54%
4	Torrent Pharmaceuticals Limited ₹256.14 Cr	Pharmaceuticals & Biotechnology	3.33%	4.74%	+1.41%
5	Laurus Labs Limited ₹217.94 Cr	Pharmaceuticals & Biotechnology	3.64%	4.04%	+0.40%
6	Global Health Limited ₹89.96 Cr	Healthcare Services	1.47%	1.67%	+0.20%
7	Nephrocare Health Services Ltd ₹64.95 Cr	Healthcare Services	1.08%	1.20%	+0.12%
8	Dr. Lal Path Labs Limited ₹57.16 Cr	Healthcare Services	0.99%	1.06%	+0.07%
9	Concord Biotech Limited ₹102.30 Cr	Pharmaceuticals & Biotechnology	1.84%	1.89%	+0.05%

#	Stock	Sector	Jun 2026	Jul 2026	Change
1	Acutaas Chemicals Ltd ₹279.44 Cr	Pharmaceuticals & Biotechnology	6.35%	5.17%	-1.18%
2	Mankind Pharma Limited ₹98.78 Cr	Pharmaceuticals & Biotechnology	2.85%	1.83%	-1.02%
3	Max Healthcare Institute Limited ₹247.16 Cr	Healthcare Services	5.08%	4.58%	-0.50%
4	Aether Industries Limited ₹123.17 Cr	Chemicals & Petrochemicals	2.72%	2.28%	-0.44%
5	Aurobindo Pharma Limited ₹208.59 Cr	Pharmaceuticals & Biotechnology	4.17%	3.86%	-0.31%
6	Cohance Lifesciences Limited ₹93.51 Cr	Pharmaceuticals & Biotechnology	2.01%	1.73%	-0.28%
7	Fortis Healthcare Limited ₹141.75 Cr	Healthcare Services	2.87%	2.63%	-0.24%
8	Apollo Hospitals Enterprise Limited ₹268.71 Cr	Healthcare Services	5.21%	4.98%	-0.23%
9	Gland Pharma Limited ₹150.17 Cr	Pharmaceuticals & Biotechnology	3.00%	2.78%	-0.22%
10	Krishna Institute Of Medical Sciences Limited ₹107.12 Cr	Healthcare Services	2.17%	1.98%	-0.19%
11	Abbott India Limited ₹55.60 Cr	Pharmaceuticals & Biotechnology	1.22%	1.03%	-0.19%
12	Biocon Limited ₹159.64 Cr	Pharmaceuticals & Biotechnology	3.14%	2.96%	-0.18%
13	Lupin Limited ₹96.60 Cr	Pharmaceuticals & Biotechnology	1.94%	1.79%	-0.15%
14	Poly Medicure Limited ₹108.93 Cr	Healthcare Equipment & Supplies	2.16%	2.02%	-0.14%
15	Aster DM Healthcare Limited ₹197.32 Cr	Healthcare Services	3.77%	3.65%	-0.12%
16	Ajanta Pharma Limited ₹103.96 Cr	Pharmaceuticals & Biotechnology	2.05%	1.93%	-0.12%
17	Sudeep Pharma Limited ₹119.82 Cr	Pharmaceuticals & Biotechnology	2.31%	2.22%	-0.09%
18	Gufic Biosciences Ltd. ₹19.49 Cr	Pharmaceuticals & Biotechnology	0.41%	0.36%	-0.05%
19	Sai Life Sciences Limited ₹131.51 Cr	Pharmaceuticals & Biotechnology	2.47%	2.44%	-0.03%
20	Anthem Biosciences Limited ₹152.13 Cr	Pharmaceuticals & Biotechnology	2.84%	2.82%	-0.02%

What Stocks Does This Fund Hold?

33 stocks — Jul 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹686.72 Cr	Pharmaceuticals & Biotechnology	12.72%
2	Divi's Laboratories Limited ₹402.80 Cr	Pharmaceuticals & Biotechnology	7.46%
3	Acutaas Chemicals Ltd ₹279.44 Cr	Pharmaceuticals & Biotechnology	5.17%
4	Cipla Limited ₹274.02 Cr	Pharmaceuticals & Biotechnology	5.07%
5	Apollo Hospitals Enterprise Limited ₹268.71 Cr	Healthcare Services	4.98%
6	Torrent Pharmaceuticals Limited ₹256.14 Cr	Pharmaceuticals & Biotechnology	4.74%
7	Max Healthcare Institute Limited ₹247.16 Cr	Healthcare Services	4.58%
8	Laurus Labs Limited ₹217.94 Cr	Pharmaceuticals & Biotechnology	4.04%
9	Aurobindo Pharma Limited ₹208.59 Cr	Pharmaceuticals & Biotechnology	3.86%
10	Aster DM Healthcare Limited ₹197.32 Cr	Healthcare Services	3.65%
11	Biocon Limited ₹159.64 Cr	Pharmaceuticals & Biotechnology	2.96%
12	Jupiter Life Line Hospitals Limited ₹155.44 Cr	Healthcare Services	2.88%
13	Anthem Biosciences Limited ₹152.13 Cr	Pharmaceuticals & Biotechnology	2.82%
14	Gland Pharma Limited ₹150.17 Cr	Pharmaceuticals & Biotechnology	2.78%
15	Fortis Healthcare Limited ₹141.75 Cr	Healthcare Services	2.63%
16	Sai Life Sciences Limited ₹131.51 Cr	Pharmaceuticals & Biotechnology	2.44%
17	Aether Industries Limited ₹123.17 Cr	Chemicals & Petrochemicals	2.28%
18	Sudeep Pharma Limited ₹119.82 Cr	Pharmaceuticals & Biotechnology	2.22%
19	Poly Medicure Limited ₹108.93 Cr	Healthcare Equipment & Supplies	2.02%
20	Krishna Institute Of Medical Sciences Limited ₹107.12 Cr	Healthcare Services	1.98%
21	Ajanta Pharma Limited ₹103.96 Cr	Pharmaceuticals & Biotechnology	1.93%
22	Concord Biotech Limited ₹102.30 Cr	Pharmaceuticals & Biotechnology	1.89%
23	Mankind Pharma Limited ₹98.78 Cr	Pharmaceuticals & Biotechnology	1.83%
24	Lupin Limited ₹96.60 Cr	Pharmaceuticals & Biotechnology	1.79%
25	Cohance Lifesciences Limited ₹93.51 Cr	Pharmaceuticals & Biotechnology	1.73%
26	Global Health Limited ₹89.96 Cr	Healthcare Services	1.67%
27	Nephrocare Health Services Ltd ₹64.95 Cr	Healthcare Services	1.20%
28	Dr. Lal Path Labs Limited ₹57.16 Cr	Healthcare Services	1.06%
29	Abbott India Limited ₹55.60 Cr	Pharmaceuticals & Biotechnology	1.03%
30	Syngene International Limited ₹51.58 Cr	Healthcare Services	0.96%
31	Rainbow Childrens Medicare Limited ₹45.76 Cr	Healthcare Services	0.85%
32	Healthcare Global Enterprises Limited ₹39.53 Cr	Healthcare Services	0.73%
33	Gufic Biosciences Ltd. ₹19.49 Cr	Pharmaceuticals & Biotechnology	0.36%